PGNY News and Press, Progyny Inc. From 11/04/20

[[AAXN]], [[ACLS]], [[ADT]], [[AGO]], [[AIG]], [[AINV]], [[ALRM]], [[ALTR]], [[AMCR]], [[AMH]], [[AMN]], [[ANGI]], [[APPN]], [[ATGE]], [[ATRC]], [[AVLR]], [[AYX]], [[AZPN]], [[BFAM]], [[BGS]], [[BHF]], [[BIGC]], [[BILL]], [[BKNG]], [[BLDP]], [[BMRN]], [[BNFT]], [[CABO]], [[CARG]], [[CDAY]], [...

Progyny (NASDAQ:PGNY) is scheduled to announce Q3 earnings results on Thursday, November 5th, after market close.The consensus EPS Estimate is $0.06 (+100.0% Y/Y) and the consensus Revenue Estimate is $92.54M (+51.2% Y/Y).Over the last 1 year, PGNY has beaten EPS estimates 75% of the time and...

NEW YORK, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, and RMA of New York, a Manhattan-based fertility clinic, presented original research at the ...

NEW YORK, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny’s Chief Executive Officer, will partic...

Fertility health is a fast-growing space within the emerging "femtech" industry -- the area of technology that focuses on women's health. According to a report by Market Research Future, the fertility services market is expected to grow at an 8.5% rate through 2023 to reach $36 billion in total ...

Progyny (NASDAQ: PGNY )  announces that Mark Livingston, executive VP of finance, has been promoted to CFO, effective September 15, 2020. More news on: Progyny, Inc., Read more ...

NEW YORK, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that Mark Livingston, Progyny’s Executive Vice President of Finance,...

Progyny, Inc. (PGNY) Q2 2020 Earnings Conference Call August 5, 2020 04:45 PM ET Company Participants James Hart - Vice President, Investor Relations David Schlanger - Chief Executive Officer Pete Anevski - President, Chief Financial Officer and Chief Operating Officer Confere...

Progyny (NASDAQ: PGNY ) : Q2 Non-GAAP EPS of -$0.02 in-line; GAAP EPS of -$0.02 beats by $0.03 . More news on: Progyny, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Reports Second Quarter Revenue of $64.6 Million Patient Return to Treatment Faster Than Expected Issues Revenue Guidance of $323.0 to $340.0 Million for Full Year 2020, Reflecting Growth of 41% to 48% Issues Revenue Guidance of $88.0 to $95.0 Million for the Third Quarter of 2020, Reflectin...